Board Member at Ironwood Pharmaceuticals, Inc.
-Ms. Moukheibir most recently served as chief executive officer of MedDay Pharmaceuticals, or MedDay, a biopharmaceutical company that focused on nervous system disorders, from July 2019 to January 2021. She was also the chairman of the board of directors of MedDay from April 2016 to January 2021. -Prior to that, Ms. Moukheibir served as the senior advisor for finance and a member of the executive board of directors at Innate Pharma SA, an oncology company, from 2011 to 2016, and as the chief financial officer for Movetis N.V. from 2008 to 2010, when it was acquired. -Ms. Moukheibir previously served as the director of capital markets for Zeltia Group S.A. from 2001 to 2007. -Ms. Moukheibir currently serves on the board of directors of the following public companies: MoonLake Immunotherapeutics AG (Nasdaq: MLTX), Biotalys NV (EBR: BTLS) and Oxford Biomedica plc (LSE: OXB). Ms. Moukheibir also serves on the board of directors of Asceneuron SA, Noema Pharma AG, DNA Script SAS, and CMR Surgical, all of which are privately held companies. She held past directorships on the boards of directors of Ablynx NV, Cerenis Therapeutics SA, Creabilis S.A., GenKyoTex S.A., Kymab Group Limited, Orphazyme A/S and Zealand Pharma A/S. -Ms. Moukheibir has an M.A. in economics and an M.B.A. from Yale University. -Ms. Moukheibir's long leadership career in the biopharmaceutical industry, as well as her deep background in international finance, provide her with valuable business and financial expertise in support of our corporate objectives.
Source: Ironwood Pharmaceuticals, Inc. on 04/27/2023
By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Catherine Moukheibir. More specifically, you'll be able to:
Access over 2,000,000 executive and board member profiles.
Example: Catherine Moukheibir